A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV

NCT00033163 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Hepatitis B

Interventions

DRUG: Adefovir dipivoxil
DRUG: Tenofovir disoproxil fumarate

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)